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ABSTRACT
The rhizome of Atractylodes lancea (,4. lancea) (Thunh.) DC. (AL) is extensively used in Chinese,
Thai, and Japanese traditional medicines as crude extracts/decoctions or a component in various
herbal formulations, Various pharmacological activities of AL and its major constituents have
been demonstrated in vitro, ex vivo, and in animal models. Results from the toxicity studies in
animal models suggest safety profile of ALand its active constituents. Despite extensive use with
positive impression in many diseases, there has not been a clinical study that can conclusively
support its efficacy and safety profile in human. This review comprehensively summarizes current
information on the pharmacological activities of AL and their active constituents including
anticancer, anti-inflammatory, antimicrobial and antipyretic activities, as well as activities on
central nervous, cardiovascular, and gastrointestinal systems.
1. Introduction
According to the World Health Organization (WHO) report
in 2011[1], traditional medicine addresses up to two-third
of the world's population's primary health care needs.
One major component of traditional medicine is the use of
herbal medicine. A common issue of herbal medicine is the
limitation of information on their pharmacological activities
and their constituents. Traditionally, the use of herbal
medicine was based on empirical treatment and then passed
on from generation to generation. In the past 20 years, there
were more studies on pharmacological activities and the
constituents of many herbal medicines, but the information
is often published in local journals and is not extensively
disseminated. The limited access to these information
prevented many herbal medicines from being developed to
their full potential.
The rhizome of Atractylodes lancea (A. lancea) (Thunb.}
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DC. (AL) has been used widely in many countries for
various indications. This compound is called "Cangzhu"
in China, "Khod-Kha-Mao" in Thailand, and "So-jutsu"
in Japan. In Chinese traditional medicine, this rhizome is
used extensively for the treatment of several diseases such
as rheumatic diseases, digestive disorders, night blindness,
and influenza. These traditional uses are explained by the
compound's ability to eliminate dampness, strengthen the
spleen, expel wind-cold from the superficial parts of the
body, and clear away the common cold[2J. In Thai traditional
medicine, the dried rhizome of AL has been used to treat
fever and the common cold[3J. Moreover, it has also been
used as a component in Thai traditional medicine in order
to relieve gastrointestinal symptoms including dyspepsia,
flatulence, nausea, and noninfectious diarrhea. In Japan, the
rhizome of AL is a component in several Kampo medicines,
eg., Juzen-taiho-to[4] and Saireito[5,6J.
History of extensive use of this herb in mankind
has facilitated the development of this herb to its full
therapeutic potential. This has brought about this review
article, whose purpose is to aid the readers in gaining a
better understanding of the potential and toxicity of this
medicinal plant and to contribute to appropriate decision-
making in further development of AL. This review article
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2.1. Anticancer activities
2. Pharmacological activities of A. lancea (Thunb.) DC.
in a dose-dependent manner. However, this compound did
not significantly exhibit antioxidative activity determined
by the radical-scarvenging activity of 2,2-diphenyl-l-
picrylhydrazyl radical (DPPH). With regards to antitumoric
property of AL in animal models, the ethanolic extract at the
concentrations of 1 000, 3 000, and 5 000 mg/kg body weight
significantly inhibited tumor growth in CCA-xenografted
nude miceltsl. The tumor size of AL-treated group was
reduced to about 10% of that in the control group on day
40 after treatment (mean±SD: tumor volumes: (550±13)
and (20 661±126) mm" for AL-treated and control group,
respectively). At the highest dose of 5 000 mg/kg body
weight, AL significantly inhibited lung metastasis by about
95%, while in the control group lung metastasis accounted
for about 90% of total lung mass. All dose levels provided
about 2-fold prolongation of the survival time of mice
compared with the control group (mean±SD: 83.30±0.88 and
40.00±0.57d in AL-treated and control group, respectively).
Lines of evidence have suggested that either anti-
angiogenic or apoptotic-related activity or both, might
at least in part contribute to cytotoxic activity of AL.
Tsuneki et alll 6] investigated the anti-angiogenic activity
of ~ -eudesmol, the main constituent of AL, both in
vitro and in vivo. The proliferation of various endothelial
cells including porcine brain microvascular endothelial
cells (PBMEC) derived from cerebral microvessel, human
dermal microvascular endothelial cells (HDMEC) derived
from peripheral microvessels, and human umbilical vein
endothelial cells (HUVEC) derived from peripheral veins,
were markedly inhibited by ~ -eudesmol at concentrations
ranging from 50 to 100 f1. M. Moreover, ~ -eudesmol also
showed a broad spectrum of anti-angiogenic effects not only
on blockade of the phosphorylation of extracellular signal-
related kinase (ERK) 1/2 induced by basic fibroblast growth
factor (bFGF) or vascular endothelial growth factor (VEGF),
but also on prevention of endothelial tube formation and
inhibition of cell migration stimulated by bFGF. In animal
model, ~ -eudesmol significantly inhibited angiogenesis
of subcutaneously implanted Matrigel plugs in mice and
adjuvant-induced granuloma in miceltel. These results were
consistent with the observations by Ma et al[17], showing an
inhibitory effect of ~ -eudesmol (50-100 f1. M) in HUVEC
induced by VEGF and bFGF. Apart from HUVEC, Hela
(human cervical cells), the proliferation of SGC-7901 (human
gastric cancer cells), and BEL-7402 (human liver cancer
cells) were also inhibited by ~ -eudesmol (10-100 f1. M)
in a time- and dose-dependent manner. Furthermore, ~
-eudesmol (2.5-5 mg/kg) significantly inhibited tumor
growth in mice implanted with H22 and S180 tumor cells
and also obviously inhibited vascular index (calculated
by carmine content in the tumor tissues divided by tumor
tissue weight)[17]. Recently, Zhao et alll 8] demonstrated that
AL extract inhibited the growth of human gastric cancer
cells in a dose- and time-dependent manner, and proposed
that the cytotoxic mechanism of AL was related to apoptosis
tract lodintra t l ne~ - l
will focus on the pharmacological activities of the crude
extract of AL rhizome including its major constituents: ~
-eudesmol, hinesol, atractylone and atractylodin[7-9].
Several conventional anticancer drugs being used in
patients with cancers are derived from plants. These
include vinblastine, vincristine, etoposide, teniposide,
paclitaxel, vinorelbine, docetaxel, topotecan, and irinotecan,
all of which have been approved by the US Food and Drug
Administrationltol, Moreover, there are several herbal
medicines of which their promising anticancer activities
were demonstrated in laboratory experiments and clinical
trialslul. Recently, it appears that the rhizome of AL is a
promising candidate herbal plant for further development as
anticancer drugs, particularly as an alternative treatment in
patients with cholangiocarcionma (CCA), the cancer of bile
duct.
The anticancer activities of AL particularly anti-CCA have
been demonstrated in several studies both in vitro and in
vivo. of a total of 28 plants and 5 herbal formulations used
in Thai traditional medicine investigated for their cytotoxic
activities, the crude ethanolic extract of AL rhizome was
shown to exhibit the most potent and selective activity
against CCA cell line (CL-6) with ICso (concentration
which inhibits cell growth by 50%) of (24.09±3.40) (mean
±SD) f1. g/mL and SI (selectivity index) of 8.6[121. Results
of the in vitro screening of tumoricidal properties of
international medicinal herbs conducted in the United
States also confirmed the anticancer activity of ALin murine
neuroblastoma cells originally derived from a spontaneous
malignant tumor with moderate to strong activity with LCso
(50% lethal concentration, the concentration which causes
50% cell death) of 0.704 mglmI1l3J. These two studies have
caught researchers' attentions to further investigate the
anticancer property of AL. Based on calcein-AM and
Hoechst 33342 assays, the cytotoxic activity of the ethanolic
extract of AL against CL-6 was found to be more potent and
more selective than the standard anticancer 5-fluorouracil
(5-FU)[141. Additionally, AL also exhibited significant
inhibitory effects on clonogenic survival, tube formation, and
invasion of CL-6 cells through a basement membrane model
Figure 1. 'The chemical structures of major components of A. lancea
(Thunb.) DC.
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and cell cycle arrest through mitochondria-dependent and
death receptor-dependent apoptotic pathways. Further
investigation should focused on the mechanism of action of
anticancer property of AL in CCA, identification of its active
constituents, as well as confirmation of its clinical efficacy
and safety in CCA patients.
2.2. Pharmacological activities on nervous system
Although neither serious adverse effect on central nervous
system (CNS) nor any morbidity has been reported in human
so far, the use of AL in human should be with caution in
patients with nervous problems due to its various effects
on nervous system. The pharmacological activity of the
rhizome extract of AL on central nervous system has been
demonstrated in various animal models with regards to its
effects on general behavior and spontaneous movement,
anti -electroshock convulsion, and potentiation of hypnotic
action of hexobarbital sodium[19J. AL extract at the highest
dose of 5 000 mg/kg body weight significantly interfered
with muscle relaxation in mice similar to that produced
by the reference drug diazepam (4 mg/kg body weight)[151.
The acetone extract of AL rhizome also showed an anti-
anoxic effect in potassium cyanide (KCN)-induced anoxia
in mice[2oJ. Nine out of ten (90%) mice treated with the AL
extract at the dose of 1 500 mg/kg body weight survived,
while none in the control group survived (OlIO: 0%). The
anti-anoxic action of AL rhizome extract was shown to be
due mainly to its active constituent ~ -eudesmol. Six out of
ten mice (60%) treated with ~ -eudesmol at the dose of 300
mg/kg body weight survived, whereas none in control group
survived (OlIO: 0%).
The effect on post-synaptic neuromuscular junction (NMJ)
of ~ -eudesmol was shown to be primarily through the
blockage of nicotinic acetylcholine receptors (nAChR) via
accelerated desensitization[21-23J. The potentiating effect
of ~ -eudesmol on NMJ was greater in diabetic than in
normal muscles[24,25J. ~ -eudesmol has been proposed
as a promising compound for potentiating neuronal
function. It was shown to induce neurite outgrowth from
rat pheochromocytoma cells (PC-12) via mitogen-activated
protein kinase (MAPK) activation[26J.
2.3. Pharmacological activities on cardiovascular system
ALextract at the dose levels of 1 000, 3 000, and 5 000 mg/kg
body weight significantly reduced the heart rate of rats, but
only the highest dose (5000 mg/kg body weight) significantly
decreased both systolic and diastolic blood pressureltel.
However, the mechanism of the anti-hypertensive effect
of AL is still unknown. The anti-platelet activity of AL
has been demonstrated in collagen-induced platelet
aggregation mode1[27J. Since it did not inhibit adrenalinel
ADP- or adrenaline/5-HT-induced platelet aggregation, its
mechanism of action has been thought to be via suppression
of collagen-induced signal pathway, the upstream of the
release of thromboxane Az (fXAz) from platelets. Altogether,
results suggest that care should be taken when using AL
extract or its active constituents in patients with platelet
disorders or coagulopathy.
2.4. Pharmacological activities on gastrointestinal system
The pharmacological effects of AL and its constituents
on gastrointestinal system support their clinical use for
alleviation of digestive symptoms in traditional medicine.
AL extract has been shown to delay gastric emptying and
stimulate small intestinal motility. The mechanisms of
its action on these activities could be through either the
inhibition of both dopamine D, and 5-HT3 receptorslzsl, or
activation of vagal tone and inhibition of corticotropin-
releasing factor (CRF)[29J. The main activity was shown to be
due to the atractylodin componentl30I.
ALextract at the dose levels of 1 000, 3 000, and 5 000 mg/kg
body weight produced an anti-ulcer effect at similar
potency as the reference drug omeprazole given at a dose of
20 mg/kg body weightl151. Results from a previous study in
pylorus-ligated rats suggest that the mechanism of action
of AL extract on anti-ulcer activity might be mediated
through inhibition of gastric secretion and reduction of
effects on histamine-induced ulceration and stress-
induced ulceration[31J. ~ -eudesmol is thought to be an
active compound which exerts inhibitory effect on gastric
secretion stimulated by histamine. The compound could
prevent gastric ulceration as effectively as cimetidine at
the same dose level (10 mg/kg body weight)[32J. Apart from
~ -eudesmol, the anti-ulcer activity of AL was also shown
with hinesol, another main constituent in AL extract at the
dose of 100 mg/kg body weight. Further investigation should
be performed to elucidate the mechanisms of action of AL
and its constituents on gastrointestinal system.
2.5. Otherpharmacological activities
The anti-inflammatory activity of AL might be due to the
contribution of several of its active constituents through
various mechanisms. The lipophilic extract from AL rhizome
exhibited potent inhibitory effect against 5-lipoxygenase
(5-LOX) and cyclooxygenase-l (COX-I) with ICso of 2.9
and 30.5 I-lg/mL, respectively[331. Isolated compound that
exhibited potent inhibitory activities against both enzymes
was shown to be atractylochromene (ICso for 5-LOX and
COX-l =0.6 and 3.3 I-lM, respectively). Despite relatively
low potency on COX-l (ICso =64.3 I-lM), quinone, another
isolated compound, showed a selective inhibitory activity
against 5-LOX (ICso =0.2 I-lM). Atractylone also exhibited
inhibitory effects against 5-LOX but with potency about
100-fold lower than quinone (ICso =25.1 I-lM). The study
conducted by Seo et al[341 demonstrated that the anti-
inflammatory effect of ~ -eudesmol was via regulation of
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Table 1
The pharmacological activities of A. lancea (Thunb.) DC. and its compounds
Pharmacological activity Model Active ingredient Mechanism of action Reference
Anti-tumour activities
Cytotoxic activity In vitro 50% Ethanol extract 50 毺g/mL [12]
In vitro 50% Ethanol extract 50 毺g/mL [14]
In vitro Petroleum ether fraction, ethyl 
acetate fraction, n-butanol 
fraction, and water fraction of AL 
0.0625-1 mg/mL
- Induction of cell apoptosis via 
the mitochondrial pathway
[18]
In vitro 100% Ethanol extract 5 mg/mL [13]
In vitro P r e n y l a t e d 
d i h y d r o b e n z o f u r a n 
derivative
[44]
Anticancer activity Mice 50% Ethanol extract 1 000-5 000 
mg/kg
[15]
Anti-angiogenic activity In vitro 毬-eudesmol 50 and 100 毺M 毬-eudesmol - Inhibition of the endothelial 
cell proliferation
- Suppression of DNA synthesis
- Inhibition of endothelial cell 
migration
- Inhibition of tube formation 
by endothelial cells
- Blockage of bFGF- and 
V E G F - i n d u c e d  E R K 1 / 2 
a c t i v a t i o n  ( o n l y  a t  t h e 
concentration of 100 uM)
- Inhibition of phosphorylation 
of CREB induced by VEGF 
in the growth factor signaling 
pathway
[16]
m s . ical )421-
interleukin-6 (IL-6) production and expression through
regulation of the p38 MAPK and nuclear factor (NF)- Ie B. In
addition, it also suppressed receptor-interacting protein 2
(RIP2)!caspase-l activation induced by phorboll2-myristate
13-acetate calcium ionophore A23187 (PMACI).
The antimicrobial activity of AL against various micro-
organisms has been demonstrated in various studies
including Staphylococcus aureus[35l, Escherichia coli[35,36l,
Saccharomyces cerevisiae, and Candida albicans[36J.
Moreover, the growth of some fungi species, such as
Rhodotorula glutinis and Saprolegnia, was also inhibited by
the volatile oil extract of AW7J. The activity on Rhizopus and
Absidia was however, relatively weak.
Although ALextract did not produce any significant central
or peripheral analgesic effects, it was shown to produce an
antipyretic effect at a dose of 5 000 mg/kg body weight in
the rat modelltsl, This antipyretic activity supports its use
for relieve fever and cold as indicated in Thai traditional
medicine.
3. Safety proflles of A. lancea (Thunb.) DC.
AL rhizome showed safety profiles in various animal
models. Following administration of AL extract at the high
dose level of 5 000 mglkg body weight in rats and mice, no
significant toxicity except stomach irritation and general
CNS depressant signs (reduced alertness and locomotion and
diminished response to touch and balance) was observedltsl,
Results from the acute and subacute toxicity tests both in
rats and mice indicated safety profiles of AL in a broad
range of dose levels (1 000-5 000 mglkg body weight).
Several clinical studies of AL have been conducted in
patients with different diseases/symptoms using AL in the
forms of various formulations[4,38-41l; however, there has
been no clinical study conducted using AL extract or its
major constituents alone. This thus signifies the needs for
further investigations in clinical trials to prove their clinical
efficacy and safety profiles in humans. Despite the lack
of clinical studies to directly support its safety in human,
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Mice 毬-eudesmol 0.90 毺mol/kg 毬-eudesmol [16]
In vitro 毬-eudesmol 50 and 100 毺M 毬-eudesmol - Inhibition of the growth factor 
signaling pathway by depressing 
activation of ERK-MAPK
-  S u p p r e s s i o n  o f  C R E B 
activation in growth factor 
signaling pathway
[17]
Mice 毬-eudesmol 2.5-5 mg/kg 毬-eudesmol [17]
In vitro 50% Ethanol extract 25-100 毺
g/mL
[14]
Anti-clonogenic activity In vitro 50% Ethanol extract 12.5-50 毺
g/mL
[14]
Inhibitory activity on cell 
invasion
In vitro 50% Ethanol extract 12.5-150 
毺g/mL
[14]
Pharmacological activities on nervous system
NMJ blocking activity Ex vivo 毬-eudesmol 200 毺M 毬-eudesmol - Blockade of nicotinic ACh 
receptors by accelerating the 
desensitization of the nicotinic 
ACh receptor
[21]
Ex vivo 毬-eudesmol 20 毺M 毬-eudesmol - Blockade of closed state of 
nicotinic ACh receptors by 
accelerating the desensitization 
of the nicotinic ACh receptor 
[23]
Ex vivo 毬-eudesmol 20 毺M 毬-eudesmol - Depression of the regenerative 
release of ACh during repetitive 
stimulation
[22]
Ex vivo 毬-eudesmol 80 毺M 毬-eudesmol [25]
CNS activity on neuronal 
differentiation
In vitro 毬-eudesmol 100 and 150 毺M 毬-eudesmol - Induction of neurite outgrowth 
mediated by MAPK activation
[26]
Anti-anoxic activity
Mice 毬-eudesmol 300 mg/kg 毬-eudesmol [20]
M o t o r  c o o r d i n a t i o n 
impairment
Mice 50% Ethanol extract 5 000 mg/kg [15]
CNS depressant activity Mice Benzene extract 200-1 000  mg/
kg
[19]
Pharmacological activities on cardiovascular system
A n t i - h y p e r t e n s i v e 
activity
Rats 50% Ethanol extract 5 000 mg/kg [15]
Anti-platelet activity In vitro Crude extract 30-1 000 毺g/mL - Inhibi t ion o f  col lagen-
induced signal pathway, which 
is upstream of the release of 
TXA2 from platelets
[27]
Pharmacological activities on gastrointestinal system
Anti-ulcer activity Rats 50% Ethanol extract 1,000-5 000 
mg/kg
[15]
Rats Benzene extract 500 mg/kg [19]
Rats 50% Methanol extract 200 mg/kg - Inhibition of gastric secretion 
by histamine H2-receptor 
blocking
[31]
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Rats 毬-eudesmol 50 mg/kg 毬-eudesmol - Inhibition of gastric secretion 
by histamine H2-receptor 
blocking
[32]
Rats Hinesol 100 mg/kg Hinesol - Inhibit gastric secretion by 
unknown mechanism
[32]
Improvemen t  o f  t he 
delayed gastric emptying
Rats Ethanol extract 30-120 mg/kg - Inhibition of the CRF release 
- Activation of vagal pathway
- Involvement in the release 
of gastrointestinal hormones 
such as motilin, gastrin and 
somatostatin
[29]
Rats Water extract 250 mg/kg and 
Atractylodin and its derivatives 
0.1-0.3 mg/kg
Atrac ty lodin  and i t s 
derivatives
[30]
I n t e s t i n a l  m o t i l i t y 
stimulation
Mice Water extract 500-1 000 mg/kg 
and 毬-eudesmol 50-100 mg/kg
毬-eudesmol - Inhibition of the dopamine D2 
receptor and the 5-HT3 receptor
[28]
Other pharmacological activities
A n t i - i n f l a m m a t o r y 
activity
Rats 50% Ethanol extract 5 000 mg/kg [15]
In vitro 毬-eudesmol 2, 20 毺M 毬-eudesmol - Regulation of IL-6 through 
regulation of the p38 MAPK and 
NF-毷B
-  S u p p r e s s i o n  o f  R I P 2 
expression and caspase-1 
activation
[34]
In vitro A t r a c t y l o c h r o m e n e , 
Quinone, Atractylon
Inhibition against 5-LOX and 
COX-1
[33]
Mice Atractylenolide I 300 mg/kg Atractylenolide I [45]
Antipyretic activity Rats 50% Ethanol extract 5 000 mg/kg [15]
Antimicrobial activity 
- against  E. col i ,  S . 
cerevisiae, and C. albicans
In vitro 95% Ethanol extract 200 mg/mL [36]
- against  E. col i ,  S . 
aureus
In vitro Atractylodin derivatives [35]
- against
Rhodotorulaglutinis and 
Saprolegnia
In vitro [37]
AL, Atractylodes lancea; bFGF, basic fibroblast growth factor; VEGF, vascular endothelial growth factor; ERK, extracellular signal-regulated 
kinase; CREB, cyclic adenosine monophosphate (cAMP) response element binding protein; NMJ, neuromuscular junction; ACh, acetylcholine; 
TXA2, thromboxane A2; CRF, Corticotropin-releasing factor; IL, interleukin; MAPK, mitogen-activated protein kinase; NK-毷B, nuclear 
factor-毷B; RIP2, receptor-interacting protein 2; LOX, lipoxygenase; COX, cyclooxygenase. 
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available information has indicated no serious adverse event
when they were administered in humans. Ayurved Siriraj
herbal recipe Chantaleela which consists of 60.6 mg AL in
each tablet (250 mg/tablet) was administered to healthy male
and female volunteers at the dose of 545.4 mg of AUd for 1 d
(divided into 3 doses, administered every 8 h). No adverse
event was observed in any subject for 10 d follow-up[42J.
Moreover, observational study conducted in China showed a
safety profile of "Fufang Cangzhu Tang", a Chinese herbal
formula which contains 15 g Atractylodes rhizome decocted
into 300 mL of liquor and separately administered orally
twice a day for 8 weeks in 32 senile patients with obesity or
overweight complicated with impaired glucose tolerance[43].
4. Conclusion
AL rhizome has been shown to exhibit vanous
pharmacological activities including anticancer activities,
activities on nervous and gastrointestinal systems, as well
as anti-hypertensive, anti-platelet, anti-ulcer, anti-
inflammatory, antimicrobial, and antipyretic activities.
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Despite extensive use with positive impression, there has
not been a clinical study that can conclusively support its
efficacy and safety profile. Further investigations should
focus on the application of AL in patients with different
diseases/symptoms. In addition, more investigation is
required to identify the specific mechanisms of certain
pharmacological activities, including anticancer activities of
AL, and its active constituents.
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